Cover Image

Use of C-reactive protein for prediction of sinus rhythm maintenance after pharmacologic cardioversion in patients with Metabolic Syndrome

Approximately 50% of patients undergoing cardioversion present with a recurrence of Atrial Fibrillation ( AF) within 3-6 months of cardioversion despite ongoing antiarrhythmic treatment (AAD). Inflammation has been involved in the pathogenesis of both metabolic syndrome (MS) and atrial fibrillation....

Full description

Saved in:
Bibliographic Details
Main Authors: Jani Ylber (Author), Neziri Entela (Author), Paparisto Sokol (Author), Bara Petrit (Author), Haxhirexha Kastriot (Author), Pocesta Bekim (Author), Rexhepi Atila (Author), Xhunga Sotiraq (Author), Serani Artur (Author), Ferati Fatmir (Author), Zeqiri Agim (Author), Kamberi Ahmet (Author)
Format: Book
Published: Sciendo, 2024-03-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Approximately 50% of patients undergoing cardioversion present with a recurrence of Atrial Fibrillation ( AF) within 3-6 months of cardioversion despite ongoing antiarrhythmic treatment (AAD). Inflammation has been involved in the pathogenesis of both metabolic syndrome (MS) and atrial fibrillation. Evidence has indicated that inflammatory changes is essential for recurrence of AF. Therefore, identifying patients at high risk of AF recurrence remains challenging.
Item Description:2734-6382
10.2478/rjc-2024-0003

Similar Items